Advanced Search
YANG Yinghong, LIAN Yuan'e, ZHAO Wenxin, FENG Changyin. A Study on Clinicopathology of Papillary Thyroid Microcarcinoma and Central Lymph Node Dissection during Operation[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 856-859. DOI: 10.3971/j.issn.1000-8578.2013.09.009
Citation: YANG Yinghong, LIAN Yuan'e, ZHAO Wenxin, FENG Changyin. A Study on Clinicopathology of Papillary Thyroid Microcarcinoma and Central Lymph Node Dissection during Operation[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 856-859. DOI: 10.3971/j.issn.1000-8578.2013.09.009

A Study on Clinicopathology of Papillary Thyroid Microcarcinoma and Central Lymph Node Dissection during Operation

More Information
  • Received Date: August 19, 2012
  • Revised Date: February 15, 2013
  • Objective To study clinicopathology of papillary thyroid microcarcinoma (PTMC) and how to dissect the central compartment lymph node during operation. Methods The clinicopathologic data of 125 cases with PTMC(in 2010) were reviewed and the diagnostic criterion of PTMC were analyzed. Pathological data of PTMC among recent 3 years were compared. Results In 125 patients of PTMC, 17 was males(13.6%),107 females(85.6%) and 1 unrecorded. 64 cases(51.2%) were more than 45ys and 58 cases(46.4%) were less than 45ys. The cancer locations were as follows: left side 49 cases(39.4%), right side 63 cases (50.4%), bilateral 12 cases(9.6%), and isthmus 1 cases. The frozen section during operation was performed in 121 cases. The right diagnosis was observed in 113 cases (accuracy rate 93.4%), and missed diagnosis in 8 cases (error rate 6.6%). Ninty-two cases had ipsilateral compartment lymph node dissection, of whom, 28 cases were found lymph node metastasis(30.4%). Among the PTMC cases, patients with the primary lesion ≥0.5 cm had slightly higher central node metastasis, compared with those with lesion <0.5 cm,34.0% (18/53) vs.25.6%(10/39), P=0.391. Conclusion A prophylactic dissection of central compartment lymph nodes should be performed to PTMC diagnosed by intraoperative frozen section.
  • [1]
    Wang Yu,Ji QH,Huang CP,et al.Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma[J].Zhonghua Wai Ke Za Zhi,2008, 46(24):1899-901.[王宇, 嵇庆海,黄彩平,等. 甲状腺乳头状微癌Ⅵ区淋巴结转移相关因素分析[J]. 中华外科杂志, 2008, 46(24):1899-901.]
    [2]
    Li XL,Gao M,Zhen XQ,et al.Clinical and biological characteristics of papillary thyroid microcarcinoma[J].Zhongguo Zhong  Liu Lin Chuang,2008, 35(23):1325-7.[李小龙,高明,郑向前等. 甲状腺乳头状微小癌的临床生物学特性研究[J].中国肿瘤临床,2008,35(23):1325-7.]
    [3]
    Gao M, Li XL,Gao SY,et al.The clinical biocharacteristics of different histopathological variants in patients of papillary thyroid carcinoma[J].Zhonghua Pu Tong Wai Ke Za Zhi,2006,21(8):588-90.[高明,李小龙,高松源,等. 甲状腺乳头状癌组织学变型的临床生物学特性[J].中华普通外科杂志,2006,21(8):588-90.]
    [4]
    Beesley MF,McLaren KM.Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules [J].Histopathology,2002,41(3):236-43.
    [5]
    Tong J,Wang Y,Da JP,et al. Usefulness of CK19,HBME-1and Galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions[J].Zhonghua Zhong Liu Za Zhi, 2011, 33(8):599-604.[佟杰,王岩,笪冀平,等.CK19 HBME-1 Galectin-3 等表达在甲状腺乳头状微小癌与良性病变鉴别诊断中的意义[J].中华肿瘤杂志,2011, 33(8):599-604.]
    [6]
    Sugitani I,Kasai N,Fujimoto Y,et al.A novel classification system for patients with PTC:addition of the new variables of large (3cm or greater) nodal metastases and reclassification during the follow-up period[J].Surgery,2004,135(2):139-48.
    [7]
    Henry JF,Gramatica L,Denizot A,et al.Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma[J].Langerbecks Arch Surg,1998,383(2):167-9.
    [8]
    Kim HY,Park WY,Lee KE, et al. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary carcinoma[J]. J Cancer Res Ther,2010,6(4):452-7.
    [9]
    Lee J,Rhee Y,Lee S,et al.Frequent, aggressive behaviors of thyroid microcarcinoma in Korean patients[J].Endocr J,2006,53(5):627-32.
    [10]
    Chow SM,Law SC,Chan JK,et al.Papillary microcarcinoma of the thyroid-prognostic signficance of lymph node metastasis and multifocality[J].Cancer,2003,98(1):31-40.
    [11]
    Shao Y,Cai XJ,Gao L,et al. Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma:clinical analysis of 117 cases[J].Zhonghua Yi Xue Za Zhi,2009,89(6):403-5.[邵雁,蔡秀军,高力,等. 甲状腺微小乳头状癌中央区淋巴结转移及临床因素分析[J]. 中华医学杂志,2009,89(6):403-5.]
    [12]
    Sun CZ,Chen FJ,Zeng ZY,et al.Treatment and prognosis of papillary thyroid microcarcinoma[J]. Zhonghua Pu Tong Wai Ke Za Zhi,2011,26 (4):283-5.[孙传政,陈福进,曾宗渊,等.甲状腺乳头状微小癌124例的治疗和预后分析[J]. 中华普通外科杂志,2011,26(4):283-5.]

Catalog

    FENG Changyin

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2351) PDF downloads (545) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return